4-PyridinecarboxiMidic acid, Methyl ester

4-PyridinecarboxiMidic acid, Methyl ester Struktur
35451-46-8
CAS-Nr.
35451-46-8
Englisch Name:
4-PyridinecarboxiMidic acid, Methyl ester
Synonyma:
Topiroxostat Impurity 81;Methyl isonicotinimidate;Methyl 4-pyridinecarboximidate;Methyl pyridine-4-carboxiMidate;4-PyridinecarboxiMidic acid, Methyl ester
CBNumber:
CB42613718
Summenformel:
C7H8N2O
Molgewicht:
136.15
MOL-Datei:
35451-46-8.mol

4-PyridinecarboxiMidic acid, Methyl ester Eigenschaften

Siedepunkt:
195℃
Dichte
1.10
Flammpunkt:
71℃
storage temp. 
2-8°C

Sicherheit

4-PyridinecarboxiMidic acid, Methyl ester Chemische Eigenschaften,Einsatz,Produktion Methoden

4-PyridinecarboxiMidic acid, Methyl ester Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


4-PyridinecarboxiMidic acid, Methyl ester Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 12)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Hangzhou MolCore BioPharmatech Co.,Ltd.
+86-057181025280; +8617767106207
sales@molcore.com China 49739 58
Amadis Chemical Company Limited
571-89925085
sales@amadischem.com China 131980 58
Shanghai Kewel Chemical Co., Ltd. 021-64609169 18901607656
greensnown@163.com China 9911 50
Struchem Co., Ltd. 0512-0512-63009836 15365350169
helen@struchem.com China 3988 60
Hubei Yangxin Medical Technology Co., Ltd. 15374522761
3003392093@qq.com China 8367 55
Aikon International Limited 025-66113011 18112977050
sales01@aikonchem.com China 16028 58
Shenyang Maud Pharmaceutical Technology Co., Ltd. 024-23982345
1020788318@qq.com China 2254 58
QUALITY CONTROL SOLUTIONS LTD. 0755-66853366; 13670046396
ORDERS@QCSRM.COM China 18899 58
Hubei De'ao Chemical Research Pharmaceutical Technology Co., Ltd 18502726233; 18502726233
3641133981@qq.com China 9701 58

  • 4-PyridinecarboxiMidic acid, Methyl ester
  • Methyl 4-pyridinecarboximidate
  • Methyl pyridine-4-carboxiMidate
  • Methyl isonicotinimidate
  • Topiroxostat Impurity 81
  • 35451-46-8
Copyright 2019 © ChemicalBook. All rights reserved